PMFA
ENSC icon

Plante Moran Financial Advisors’s Ensysce Biosciences ENSC Stock Holding History

Plante Moran Financial Advisors’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$10 – 886
2024
Q2 		$10 Hold
1
– – ﹤0.01% 778
2024
Q1 		$16 Hold
1
– – ﹤0.01% 835
2023
Q4 		$21 Hold
1
– – ﹤0.01% 813
2023
Q3 		$28 Hold
1
– – ﹤0.01% 753
2023
Q2 		$36 Hold
1
– – ﹤0.01% 781
2023
Q1 		$97 Hold
1
– – ﹤0.01% 773
2022
Q4 		$186 Buy
+1
New +$475 ﹤0.01% 815

Other funds holding ENSC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Plante Moran Financial Advisors's ENSC Position: Q3 2024 in Review

Plante Moran Financial Advisors sold out of Ensysce Biosciences (ENSC) in Q3 2024, closing a stake of 1 share — an estimated $10 sold.

Plante Moran Financial Advisors first reported a position in ENSC in Q4 2022 and held it in 7 quarters. The position peaked at $186 in Q4 2022. 12 funds tracked by Wall St. Rank hold ENSC as of Q3 2024.

  • Plante Moran Financial Advisors reported no remaining Ensysce Biosciences position as of Q3 2024 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 1 Ensysce Biosciences share in Q3 2024, an estimated $10.
  • Plante Moran Financial Advisors first reported a position in Ensysce Biosciences in Q4 2022 and held it in 7 quarters.
  • Plante Moran Financial Advisors's Ensysce Biosciences position peaked at $186 in Q4 2022.
  • 12 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q3 2024.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.